Improved survival in homozygous sickle cell disease: Lessons from a cohort study
Improved survival in homozygous sickle cell disease: Lessons from a cohort study
复制标题
DOI:
10.1136/bmj.311.7020.1600
复制
发表时间:
1995-12-16
影响因子:
--
通讯作者:
Serjeant, G
中科院分区:
文献类型:
--
作者:
Lee, A;Thomas, P;Serjeant, G
Objective-To examine whether simple interventions in a sickle cell clinic improve survival in sickle cell disease.Design-Survival curve analysis and hazard ratios in a cohort study followed from birth.Setting-MRC Laboratories (Jamaica) at the University of the West Indies, and Victoria Jubilee Hospital, Kingston, Jamaica.Subject-315 patients with homozygous sickle cell disease detected during the screening of 100 000 consecutive non-operative deliveries between June 1973 and December 1981 at the main government maternity hospital, Kingston, Jamaica.Interventions-Prophylactic penicillin to prevent pneumococcal septicaemia, parental education in early diagnosis of acute splenic sequestration, close monitoring in sickle cell clinic,Main outcome measures-Survival.Results-Survival appeared to improve, the log rank test for trend comparing the first, second, and last third of the study reaching borderline significance (P=0.05). Combined deaths from acute splenic sequestration and pneumococcal septicaemia-meningitis declined significantly (test for trend, P=0 . 02).Conclusion-Early diagnosis and simple prophylactic measures significantly reduce deaths associated with homozygous sickle cell disease.